GlassScriptPhysician profile
Brian J Roberts
NPI 1700877909
$10,604.99
in general payments reported to CMS, 2019-2025
56 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $906 · 2021: $1,976 · 2022: $2,138 · 2023: $2,103 · 2024: $1,904 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,717.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,351.89 | 2021-2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $1,126.72 | 2020-2024 | Prolaris, Myrisk |
| Teleflex LLC | $1,122.87 | 2022-2025 | Urolift, Barrigel, Solesta |
| Coloplast Corp | $592.14 | 2019-2024 | Speedicath |
| Dendreon Pharmaceuticals LLC | $523.07 | 2019-2024 | Provenge |
| Antares Pharma, INC. | $518.71 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $502.22 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $491.89 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $428.10 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $419.54 | 2019-2025 | Axonics, Rezum Generator, Spaceoar Vue System - 10ml |
| Astrazeneca Pharmaceuticals LP | $324.80 | 2020-2023 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $265.69 | 2020-2023 | |
| Laborie Medical Technologies Corp. | $243.40 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Endo Pharmaceuticals INC. | $230.58 | 2019-2024 | Xiaflex |
| Blue Earth Diagnostics | $209.40 | 2019-2025 | Posluma |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.